E. Lynne Kelley
Geen lopende functies
Profiel
E.
Lynne Kelley is currently the Chief Executive & Medical Officer at Signalexis, Inc. Previously, she held positions as Medical Director at Kimberly-Clark Corp.
and Boston Scientific Corp., Assistant Professor at Yale University, and Vice President-Medical Affairs at Becton, Dickinson & Co. She also served as Chief Medical Officer at Histogenics Corp., Senseonics Holdings, Inc., and X4 Pharmaceuticals, Inc. Kelley received her undergraduate degree from Boston University and her doctorate from Dartmouth Medical School.
Actieve functies van E. Lynne Kelley
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van E. Lynne Kelley
| Bedrijven | Functie | Einde |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 03-04-2020 |
| OCUGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 23-01-2019 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01-01-2016 |
| KIMBERLY-CLARK CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-12-2010 |
| BOSTON SCIENTIFIC CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-01-2007 |
Opleiding van E. Lynne Kelley
| Boston University | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| KIMBERLY-CLARK CORPORATION | Consumer Non-Durables |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
